摘要
患者永久性锁骨下静脉置管行维持性血液透析,低蛋白血症致血液浓缩,血液常呈高凝状态。静脉滴注尿激酶前、静脉滴注尿激酶过程中及静脉滴注尿激酶完毕后24 h内患者意识清楚,血压稳定,波动不大,患者全身无出血倾向,动、静脉管腔均通,透析治疗顺利进行,血路管、透析器无明显挂血现象。尿激酶改善了尿毒症患者的生活质量,有较高的临床应用价值。
In patients with permanent subclavian vein catheterization for hemodialysis,blood concentration induced hypoalbuminemia blood coagulation state,Chang Chenggao.Intravenous infusion of urokinase intravenous infusion of urokinase before,during and after intravenous infusion of urokinase within 24 hours after the patients with clear consciousness,blood pressure stable,volatility,patients without bleeding tendency,move,vein lumen,dialysis treatment smoothly,blood dialysis tube,for no obvious link blood phenomenon.Urokinase improves the quality of life of patients with uremia,have high value in clinical application.
作者
黄清
HUANG Qing(Hemodialysis Center,Hospital of Hubei Provincial Armed Police Corps,Wuhan 430061,Hubei,China)
关键词
尿激酶
尿毒症
高凝状态
Urokinase
Uremia
Hypercoagulable state
